Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

Presentation THT 2026

What Causes Inflammation in HFpEF? What Lights the Fire?

Presenter: Mark C. Petrie

March 02, 2026

Presentation NY Valves 2025

Inflammation Meets Intervention: Left Atrial Appendage Occlusion (LAAO) Outcomes in Patients With Rheumatoid Arthritis

Presenter: Suryakumar Balasubramanian

June 25, 2025

Presentation THT 2025

Implantable Cardiac Patch Continuously Monitors Inflammation and Acute Heart Failure Biomarkers In Vivo and Ex Vivo

Presenter: Devleena Das

February 13, 2025

Presentation THT 2025

Healthcare Professionals' Perspectives on the Treatment of Systemic Inflammation With Heart Failure and Associated Patient Journey Mapping

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

From Obesity to Inflammation: Common Pathways and New Opportunities in HF

Presenter: Milton Packer

February 12, 2025

Presentation THT 2025

Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?

Presenter: Javed Butler

February 12, 2025

Presentation THT 2025

Inflammation as a Target in Acute HF

Presenter: Gad Cotter

February 12, 2025

Presentation THT 2025

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Presenter: Barry Borlaug

February 12, 2025

Presentation THT 2025

Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence

Presenter: Marco Metra

February 12, 2025

Presentation THT 2025

Inflammation and HFpEF: Rationale for HERMES

Presenter: Mark Petrie

February 12, 2025

Presentation THT Abstracts 2025

Healthcare Professionals' Perspectives on the Treatment of Systemic Inflammation With Heart Failure and Associated Patient Journey Mapping

Presenter: Marat Fudim

February 11, 2025

Presentation THT 2025

Resurgence of Interest in the Role of Inflammation in HF

Presenter: Douglas Mann

February 11, 2025

Presentation TCT 2024

TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model

Presenter: Seok Oh

October 29, 2024

Presentation TCT 2024

Inflammation- Current and Emerging Therapeutic Landscape

Presenter: Deepak Bhatt

October 29, 2024

Presentation TCT 2024

What Comes Next? Role of Inflammation on AMI

Presenter: Kevin Bainey

October 28, 2024

Presentation TCT 2024

Inflammation: The Next Frontier

Presenter: Vijay Kunadian

October 28, 2024

Presentation Complex Coronary Cases 2023

Eliminating Coronary Artery Disease: Targeting Hypercholesterolemia and Inflammation

Presenter: Marc S. Sabatine

June 15, 2023

Presentation Controversies and Advances 2021

Pathways for Inflammation in Athero-thrombosis Focus on Inflammasome

Presenter: P. K. Shah

December 03, 2021

Presentation TCT 2019

Novel Approaches in Diabetic Patients After PCI: Role of SGLT2 Inhibitors and Potent Antiplatelet Therapy (THEMIS)

Presenter: Marc Bonaca

September 26, 2019

Presentation TCT 2019

Tackling Inflammation: Novel Targets

Presenter: Wolfgang Koenig

September 26, 2019

Advertisement

What Causes Inflammation in HFpEF? What Lights the Fire?

Inflammation Meets Intervention: Left Atrial Appendage Occlusion (LAAO) Outcomes in Patients With Rheumatoid Arthritis

Implantable Cardiac Patch Continuously Monitors Inflammation and Acute Heart Failure Biomarkers In Vivo and Ex Vivo

Healthcare Professionals' Perspectives on the Treatment of Systemic Inflammation With Heart Failure and Associated Patient Journey Mapping

From Obesity to Inflammation: Common Pathways and New Opportunities in HF

Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?

Inflammation as a Target in Acute HF

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence

Inflammation and HFpEF: Rationale for HERMES

Healthcare Professionals' Perspectives on the Treatment of Systemic Inflammation With Heart Failure and Associated Patient Journey Mapping

Resurgence of Interest in the Role of Inflammation in HF

TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model

Inflammation- Current and Emerging Therapeutic Landscape

What Comes Next? Role of Inflammation on AMI

Inflammation: The Next Frontier

Eliminating Coronary Artery Disease: Targeting Hypercholesterolemia and Inflammation

Pathways for Inflammation in Athero-thrombosis Focus on Inflammasome

Novel Approaches in Diabetic Patients After PCI: Role of SGLT2 Inhibitors and Potent Antiplatelet Therapy (THEMIS)

Tackling Inflammation: Novel Targets

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content